Hugel, Inc.
⚠️ High Risk
FEI: 3012072120 • Chuncheon-si, Gangwon-do • SOUTH KOREA
FEI Number
3012072120
Location
Chuncheon-si, Gangwon-do
Country
SOUTH KOREAAddress
61-20 Sinbuk-ro, Sinbuk-eup, , Chuncheon-si, Gangwon-do, South Korea
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
FRNMFGREG
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.
NO PMA
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the device appears to be a Class III device and does not appear to have in effect an approved application for premarket approval pursuant to Section 515 of the Act, or an exemption pursuant to Section 520(g)(1).
DRUG GMPS
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the methods used in and controls used for the manufacture, processing, packing, or holding of drugs and other products do not appear to conform to current good manufacturing practices within the meaning of Section 501(a)(2)(B).
NO ENGLISH
Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 1/8/2026 | 66YBY99EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C. | Division of Southeast Imports (DSEI) | |
| 10/27/2025 | 58PDY05ONABOTULINUMTOXINA | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 10/27/2025 | 58PDY05ONABOTULINUMTOXINA | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 6/4/2025 | 60QBY07LIDOCAINE | Division of Southeast Imports (DSEI) | |
| 5/25/2022 | 79LMHIMPLANT, DERMAL, COLLAGEN FOR AESTHETIC USE | Division of Southeast Imports (DSEI) | |
| 2/1/2022 | 65QCK02BOTOX | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 2/1/2022 | 65QCK02BOTOX | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 9/11/2020 | 65QCK02BOTOX | Division of Southeast Imports (DSEI) |
Frequently Asked Questions
What is Hugel, Inc.'s FDA import refusal history?
Hugel, Inc. (FEI: 3012072120) has 8 FDA import refusal record(s) in our database, spanning from 9/11/2020 to 1/8/2026.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Hugel, Inc.'s FEI number is 3012072120.
What types of violations has Hugel, Inc. received?
Hugel, Inc. has been cited for 7 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Hugel, Inc. come from?
All FDA import refusal data for Hugel, Inc. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.